v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net income $ 5,636 $ 5,619
Increase (decrease) in cash from operating assets and liabilities:    
Accounts receivable (635) 345
Inventories and other assets 82 (125)
Accounts payable and accrued expenses 330 29
Depreciation and amortization 2,828 2,612
Income taxes 98 1,314
Losses (gains) on sales of facilities (22) 4
Amortization of debt issuance costs and discounts 34 32
Share-based compensation 304 301
Other 155 146
Net cash provided by operating activities 8,810 10,277
Cash flows from investing activities:    
Purchase of property and equipment (3,707) (3,455)
Acquisition of hospitals and health care entities (942) (361)
Sales of hospitals and health care entities 107 177
Change in investments (214) (26)
Other 1 (6)
Net cash used in investing activities (4,755) (3,671)
Cash flows from financing activities:    
Issuance of long-term debt 2,994 5,233
Net change in short-term borrowings and revolving credit facility 3,507 1,906
Repayment of long-term debt (2,713) (5,834)
Distributions to noncontrolling interests (574) (631)
Payment of debt issuance costs (17) (57)
Payment of dividends (519) (517)
Repurchase of common stock (6,605) (7,509)
Other (256) (142)
Net cash used in financing activities (4,183) (7,551)
Effect of exchange rate changes on cash and cash equivalents (4) 9
Change in cash and cash equivalents (132) (936)
Cash and cash equivalents at beginning of period 1,040 1,933
Cash and cash equivalents at end of period 908 997
Interest payments 1,725 1,696
Income tax payments, net $ 1,417 $ 227